C. Wigerup
Cancer Research · 2016
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Cancer Research — 54 citations into it
- Molecular Biology — 40 citations into it
Whom C. Wigerup trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- G. Semenza
- Huafeng Zhang
- Cheng-Jun Hu
- P. Vaupel
- William R. Wilson
- E. White
- John D. Gordan
- Jung-whan Kim
- B. Keith
- Jessica A. Bertout
Papers from C. Wigerup's perspective
Ordered by how strongly the researchers C. Wigerup trusts endorse each paper. Same corpus, a different order for every researcher.
- Targeting HIF-1 for cancer therapy (Nature Reviews. Cancer)
- Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation (Molecular and Cellular Biology)
- HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing (Science)
- Contrasting Properties of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-Associated Renal Cell Carcinoma (Molecular and Cellular Biology)
- Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer (Nature Medicine)
- HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. (Cell Metabolism)
- FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. (Genes & Development)
- Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. (Journal of the National Cancer Institute)
- Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. (Cancer Cell)
- Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor… (Cancer Research)
Their papers
- Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer. (2016) — 620 citations